###begin article-title 0
Plasma Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Obsessive Compulsive Disorder
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aim</italic>
###xml 340 345 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 389 396 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 427 432 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 548 553 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 649 656 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 667 672 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 770 771 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 780 781 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 863 868 847 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 876 877 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 886 888 866 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> P</italic>
###xml 961 962 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 971 972 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1000 1010 980 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusion</italic>
###xml 1049 1054 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 379 387 <span type="species:ncbi:9606">patients</span>
###xml 739 747 <span type="species:ncbi:9606">patients</span>
###xml 984 992 <span type="species:ncbi:9606">patients</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
Aim. Recent research implicated place of an immune mechanism in the pathophysiology of obsessive-compulsive disorder (OCD). Despite increasing evidence involvement of cytokine release in OCD, results of the studies are inconsistent. The aim of this study was to evaluate the plasma levels of the cytokines; tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in OCD patients. Methods. Plasma concentrations of TNF-alpha and IL-6 were measured in 31 drug-free outpatients with OCD, and 31-year age and sex-matched healthy controls. TNF-alpha and IL-6 concentrations in blood were determined by enzyme-linked immunosorbent assay (ELISA). Results. Both TNF-alpha and IL-6 levels showed statistically significant increases in OCD patients compared to controls (P < .000, P < .001, resp.). In addition, the age of onset was negatively correlated with TNF-alpha level (r = -.402, P = .025) and duration of illness was weakly correlated with IL-6 levels (r : .357; P : .048) in patients group. Conclusion. OCD patients showed increases in TNF-alpha and IL-6 levels compared to the healthy controls. This study provides evidence for alterations in the proinflamatory cytokines which suggest the involvement of the immune system in the pathophysiology of OCD.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
Previous studies implicated the role of the immune system in the pathogenesis of a variety of neuropsychiatric disorders, including depression [1], dementia [2], and schizophrenia [3]. Various immune parameters have also been investigated in some anxiety disorders such as posttraumatic stress disorder [4], panic disorder [5], social phobia [6], and OCD. Recent reports have indicated the presence of immune system alterations in OCD patients. Despite the strong recent interest in immunologic abnormalities in OCD, few studies have examined cytokines in this disorder [7-9].
###end p 4
###begin p 5
###xml 356 361 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 405 406 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 407 409 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 463 465 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
OCD is characterized by intrusive, unwanted, and recurrent thoughts (obsessions) and/or repetitive ritualistic behaviors (compulsions). It has been suggested that proinflammatory cytokines are involved in the etiopathogenesis of OCD. These results suggest the existence of a possible immune dysfunction in OCD. While some authors reported decreases of TNF-alpha, IL-6, and natural killer (NK) activities [8-11], others found increase of NK cells in OCD patients [12].
###end p 5
###begin p 6
###xml 417 421 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 447 449 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 107 113 <span type="species:ncbi:9606">people</span>
###xml 345 353 <span type="species:ncbi:9606">children</span>
An association of OCD with infectious disease and alterations in immune function was first considered when people who had recovered from von Economo's encephalitis began to present neuropsychiatric symptomps. In addition recent research revealed an association between OCD and streptococcal infections. It has been hypothesized that subgroup of children with OCD develops the illness following infection with Group A beta-hemolytic streptococcus [13].
###end p 6
###begin p 7
###xml 82 87 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 155 160 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 312 314 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 321 326 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 421 423 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 424 426 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 509 511 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 675 677 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 841 843 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 845 847 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
The most extensively investigated cytokines in neuropsychiatric disorders are TNF-alpha and IL-6 due to their effects on central nervous system (CNS). TNF-alpha is produced by macrophages and circulating monocytes, and plays an important role in a variety of infectious, inflammatory, and autoimmune conditions [14]. TNF-alpha also affects central processes directly or indirectly through stimulation of vagal afferents [15-17]. Thus, this cytokine has been emerging as an important role of the CNS function [18]. IL-6 acts on a variety of cells, regulating immune response, acute phase reaction, and is implicated in the pathogenesis of autoimmune and inflammatory disease [19]. IL-6 is synthesized and colocalized with its own receptors in the brain, and it is expressed in small quantities in the CNS even in the absence of inflammation [20, 21].
###end p 7
###begin p 8
###xml 311 316 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
Although several studies have suggested the existence of an association between OCD and cytokine levels alteration, the findings are not consistent. Therefore, a thorough investigation of the immune system function in OCD is still warranted. In this study we have measured plasma concentrations of IL-6 and TNF-alpha in OCD patients, with the aim to see whether or not the release of these two proinflammatory cytokines is altered and if they correlate with the type of psychopathology, severity, age of onset, and duration of illness.
###end p 8
###begin title 9
2. MATERIAL AND METHODS
###end title 9
###begin title 10
2.1. Subjects
###end title 10
###begin p 11
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
The study was conducted between October 2004 and July 2006. All patients were recruited from the psychiatry outpatients unit of Zonguldak Karaelmas Medical Faculty Hospital. The Local Ethic Commitee approved the study protocol. All subjects were asked to participate and they provided written informed consent. At the initial assessment, the study group was evaluated by psychiatrists (authors) using the Structured Clinical Interview for DSM-IV, Clinical Version (SCID-I/CV) [22, 23].
###end p 11
###begin p 12
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 521 529 <span type="species:ncbi:9606">Patients</span>
###xml 624 632 <span type="species:ncbi:9606">Patients</span>
Subjects were excluded if they had evidence of traumatic injury, clinically unstable medical illness such as hepatic or renal impairment; a history of seizure, head trauma, or stroke, active infection, allergy, rheumatoid disease, cancer, and any other primary disease interfering with immune functions. The patients who were using psychotropic agents (antidepressants, anxiolytics, antipsychotics) and/or analgesics (including nonsteroidal anti-inflammatory drugs) within the last 3 months were excluded from the study. Patients who had history of alcohol or substance abuse and heavy cigarette smoking were also excluded. Patients smoking cigarettes more than 20 per day were considered heavy smokers.
###end p 12
###begin p 13
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
###xml 251 258 <span type="species:ncbi:9606">patient</span>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 520 528 <span type="species:ncbi:9606">patients</span>
Fifty-three consecutive patients with OCD were included in the study. Ten patients were excluded since they were not drug-free at baseline, six patients excluded since they had the medical illness mentioned above, and five refused to participate. One patient excluded because of extreme value for IL-6. The final sample encompassed 31 patients (17 females and 14 males, mean age 33.4 +/- 10.9 years, range 21-64 years). Six of the patients were drug-free and 25 of patients were drug-naive at the study entrance. Of the patients 38.7% had a depressive disorder and 35.4% had comorbid anxiety disorders. The gender and age matched 31 healthy comparison subjects were recruited from the university hospital staff and friends of the staff members (15 females and 16 males, mean age 32.7 +/- 8.5 years, range 19-60 years) as controls.
###end p 13
###begin p 14
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
The severity of symptoms was assessed by means of the Yale Brown Obsessive-Compulsive Scale (Y-BOCS), [24]. The levels of depression and anxiety were also assessed using the Hamilton Anxiety Rating Scale [25] and 17-item Hamilton Depression Rating Scales [26], which are rated by physicians. These scales have been demonstrated to be valid and reliable in Turkish population studies [27, 28].
###end p 14
###begin title 15
2.2. Elisa
###end title 15
###begin p 16
###xml 302 307 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 524 529 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Ten ml of heparinized venous blood were collected with the plastic tubes from subjects at 08.00 a.m. Blood samples were santrifuged at 3000 rpm (rotor diameter: 16 cm) and preserved at -80degreesC. Analyses were performed by the immunologists, who were blind to the condition of the samples. IL-6, TNF-alpha enzyme-linked immunosorbent assay (ELISA) kits were purchased by Biosource International Inc.(Camarillo, Calif, USA) and used according to the recommendations of the manufacturer. The minimum detectable doses of TNF-alpha and IL-6 are 1.1 pg/ml, 2.2 pg/ml, respectively. There is no cross-reactivity with other cytokines. All samples were assayed in duplicate.
###end p 16
###begin title 17
2.3. Statistics
###end title 17
###begin p 18
###xml 311 316 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 318 319 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 334 335 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 517 518 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 297 305 <span type="species:ncbi:9606">patients</span>
###xml 345 353 <span type="species:ncbi:9606">Patients</span>
Results were analyzed at the computer by using the Statistical Package for the Social Sciences for Windows release 11.01, Chicago Illionis (customer no. 114094). Data were expressed as mean +/- standard deviation. The Kolmogorov-Smirnov test was used to evaluate the normality of the data for OCD patients (TNF-alpha; P = .031, IL-6: P = .000). Patients and controls test scores were compared by the Mann Whitney U test as the data not distributed normally. The differences were considered to be significant when the P value was less than .05. All tests performed were two-tailed. In addition Spearman correlation tests were performed in order to test intercorrelations between clinical findings such as Y-BOCS total and subscale scores age, age at onset, duration of illness, and cytokine levels in OCD group.
###end p 18
###begin title 19
3. RESULTS
###end title 19
###begin p 20
###xml 70 77 70 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 450 451 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 408 416 <span type="species:ncbi:9606">patients</span>
Demographic and clinical characteristics of the patients are shown in Table 1. There were a total of 62 subjects, including 31 patients (17 females and 14 males) and 31 healthy control subjects (15 females and 16 males). The mean ages (+/- standard deviation) of the patients and control subjects were 33.4 (+/-10.9) and 32.7 (+/-8.5) years, respectively. There were no significant group differences between patients and controls for age and gender (P > .05). The mean age at onset of obsessive-compulsive symptoms was 22.8 +/- 10.7 years, with a length of illness of 10.6 +/- 10.6 years at entry. The Y-BOCS total score was 23.3 +/- 8.8 (minimum 8, maximum 40), the obsession subscale total score was 11.9 +/- 4.0, and the compulsion subscale total score was 11.4 +/- 5.2. The most commonly reported obsessions were aggressive (78.9%), and the most common compulsions were cleaning (68.7%) and checking (46.9%).
###end p 20
###begin p 21
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Differences in immune system variables between the OCD patients and control subjects are shown in Table 2.
###end p 21
###begin p 22
###xml 52 57 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 65 66 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 76 77 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 168 169 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 178 179 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The age of onset was negatively correlated with TNF-alpha level (r = -.402, P = .025). There was positive weak correlation between duration of illness and IL-6 levels (r : .357; P : .048). No other correlations were found between clinical features with any of the immune parameters.
###end p 22
###begin p 23
###xml 135 140 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 183 184 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 367 368 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 442 447 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 637 638 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 659 664 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 729 734 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 153 161 <span type="species:ncbi:9606">patients</span>
When group was reanalyzed in terms of an onset of the disease, patients with an early onset before age 14 had significantly higher TNF-alpha levels than patients with nonearly onset (P = .018). Nonparametric Kruskal Wallis tests with adjustment by Bonferroni correction were conducted to evaluate whether the differences were significant between two compared groups (P < .0016) (early onset, nonearly onset and control groups). Levels of TNF-alpha (16.8 +/- 9.0, 9.9-39.2) and IL-6 (16.9 +/- 16.0, 6.5-54.9) were significantly increased in early onset group compared with nonearly onset and healthy controls (Kruskal Wallis, Asymp. Sig. P < .000 for both TNF-alpha and IL-6). In contrast there was no significant increase in TNF-alpha and IL-6 between nonearly onset and healthy controls.
###end p 23
###begin title 24
4. DISCUSSION
###end title 24
###begin p 25
###xml 25 30 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 212 213 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 214 216 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 428 433 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 484 489 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 598 603 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 640 641 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 642 644 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 646 648 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 655 660 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 806 808 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 441 449 <span type="species:ncbi:9606">patients</span>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
In our investigation TNF-alpha and IL-6 plasma levels were significantly higher in OCD patients compared to healthy controls. Our results corroborate the findings of previous studies on immune alteration in OCD [7-13]. However to date in the literature there have been limited studies on alterations of cytokines and results are conflicting. To our medline search we reached only four studies investigating plazma levels of TNF-alpha in OCD patients. The observation of increased TNF-alpha production in present study is not in accordance with these five study results that found the decreased TNF-alpha plasma levels in patients with OCD [9-11, 29]. TNF-alpha is one of the main cytokines in the inflammatory and immune responses. The alterations of serotonergic pathways have long been evidenced in OCD [30].
###end p 25
###begin p 26
###xml 34 39 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 217 222 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 265 267 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 306 311 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 382 384 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 386 388 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 354 357 <span type="species:ncbi:10116">rat</span>
It has been demonstrated that TNF-alpha may provoke variations of central neurotransmitter activity, and conversely that neurotransmitters may modulate expression. Enhancement of serotonin transporter function by TNF-alpha also has been reported by Mossner et al. [31]. Moreover, possible induction of TNF-alpha expression by serotonin has been shown in rat hippocampal astrocytes [31, 32]. Since existence of multidirectional communication among the immune system and the central nervous system has been shown, the alteration in immune function in OCD would reflect a change in neurotransmission.
###end p 26
###begin p 27
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
Study results of plasma levels of IL-6 have also been conflicting. Although most of the studies have not found an alteration in IL-6 plasma levels in OCD [7, 11, 33] we detected an increase in IL-6 levels. Inconsistencies in cytokine measurements may be due to differences in methodologies. For example sampling of CSF rather than plasma in the study of Carpenter et al. [33] may be the cause of their negative findings. As plasma levels of IL-6 measured only once in present study which cannot reflect the values of IL-6 throughout the day might be explained the differences between results.
###end p 27
###begin p 28
###xml 10 15 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 458 460 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 461 463 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 684 686 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 858 863 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
###xml 884 892 <span type="species:ncbi:9606">patients</span>
###xml 1202 1210 <span type="species:ncbi:9606">patients</span>
Since TNF-alpha and IL-6 are major proinflammatory cytokines and our findings of higher blood levels of these two cytokines support the evidence of immune activation in OCD that ongoing immune activation may be involved in the pathogenesis of OCD, most studies that have reported a normal, or an increase of proinflammatory cytokines rather than a decrease in other psychiatric disorders, namely, major depression and schizophrenia, support this hypothesis [34-36]. Moreover increased prevalence of autoimmune diseases and of antinuclear and anticytoplasmic antibodies increased serum IL-6 concentration, and an association with HLA antigens has been found in schizophrenic patients [37]. These findings are also characteristic of apparent autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis. Although the high serum levels of TNF-alpha and IL-6 in the OCD patients of our study could be suggestive of an ongoing autoimmune process, the mechanism underlying these altered cytokine levels remains unknown at present. Since the triggering of an autoimmune process depends on the inappropriate action of certain cytokines affecting various immunologic functions, studies in OCD patients assessing the levels of other cytokines or cellular responses are needed.
###end p 28
###begin p 29
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 529 534 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
###xml 620 628 <span type="species:ncbi:9606">children</span>
###xml 639 647 <span type="species:ncbi:9606">patients</span>
Another important observation in the present study was that clinical variables of OCD were related to specific alterations in immune parameters. The increased IL-6 production in our sample may still be a characteristic of a particular subgroup of OCD patients as speculated in the literature [38], or a state factor of severely ill OCD patients, as we found correlation between duration of illness and IL-6 production. We have found, in addition, that patients with a childhood onset of OCD (<14 years) had a higher level of TNF-alpha than patients with nonearly onset. Immunologic alterations appear to be different in children and adult patients probably reflect different pathophysiologic mechanisms, such as autoimmunity. We have not found any other correlation between cytokines and severity of the disease, existence of comorbid depression, anxiety, and family history of OCD.
###end p 29
###begin p 30
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 599 607 <span type="species:ncbi:9606">patients</span>
###xml 926 934 <span type="species:ncbi:9606">patients</span>
Inclusion of the untreated OCD patients in this study might explain the discrepant results from other studies. The evidence suggests that drugs such as benzodiazepines [39], antidepressants [40], and antipsychotics [41] may have significant influence on the functioning of immune system. Several studies reported normalization of the changes in a number of NK cells and level of IL-6 in depressed patients following chronic selective serotonin reuptake inhibitors treatment [42]. However, Barber et al. did not observe any change in T-lymphocyte subsets during clomipramine treatment in chronic OCD patients [43]. Olanzapine, an atypical antipsychotic, which shares similarities with clozapine in its chemical structure and neurotransmitter receptor binding profiles, has also been shown to cause cellular immune impairment [41]. Interestingly these drugs also induce obsessive compulsive symptoms in a portion of psychiatric patients during the course of treatment [44].
###end p 30
###begin p 31
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 268 276 <span type="species:ncbi:9606">patients</span>
###xml 563 571 <span type="species:ncbi:9606">patients</span>
Higher number of comorbidity in our study sample (especially presence of comorbid depressive disorder) could be taken into account to explain the diversity of the results. In earlier studies, depression alone is shown to result in changes in immune functioning of the patients [45]. The findings of present study are in line with reports indicating an increase in the production or secretion of IL-6 and IL-l in subjects with major depression [42]. However, we were not able to find any correlation between existence of comorbid depression or HAM-D scores of the patients and cytokine levels.
###end p 31
###begin p 32
###xml 351 356 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Since the size of present study groups was relatively small, we could not claim that an alteration could be detected in all OCD patients. Also as plasma levels of these cytokines measured only once, we cannot decisively say that values are higher than average levels throughout the day. It is possible, however, that cytokines other than IL-6 and TNF-alpha might be involved in this process which constitutes another limitation of this study, as we were unable to conduct assays for additional cytokines.
###end p 32
###begin p 33
###xml 268 273 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 275 277 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 331 336 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
It has been postulated that OCD may be a manifestation of poststreptococcal autoimmunity, and it is known that individuals with autoimmune pathology or systematic autoimmune diseases often exhibit increased production of proinflammatory cytokines such as IL-6 and TNF-alpha [46]. Our observations confirm an increased IL-6 and TNF-alpha production, however contradict decreased production of proinflammatory cytokines, support the postulation of an autoimmune mechanism in OCD. Since the complex network of processes responsible for the regulation of cytokines is not proven and they have various biological activities, their significance as regulators of physiology of the brain has not well understood yet, determining the significance of the alterations in immune activity in OCD is needed.
###end p 33
###begin title 34
5. CONCLUSION
###end title 34
###begin p 35
###xml 104 109 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 208 210 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 212 214 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
In conclusion, our results show an increased production of the proinflammatory cytokines, IL-6, and TNF-alpha in OCD patients. Based on the recent findings of immune abnormalities in the pathogenesis of OCD [47, 48], the present findings are of considerable significance that highlights the needs of further research in this area. Understanding of alteration of cytokine profile in the OCD may help elucidate the role of inflammation and also lead to the design of new therapeutic modalities for this disease.
###end p 35
###begin article-title 36
Depression, stress and immunological activation: the role of cytokines in depressive disorders
###end article-title 36
###begin article-title 37
Changes in the immune system in depression and dementia: causal or co-incidental effects?
###end article-title 37
###begin article-title 38
In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research
###end article-title 38
###begin article-title 39
###xml 123 126 <span type="species:ncbi:9606">man</span>
Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events
###end article-title 39
###begin article-title 40
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy
###end article-title 40
###begin article-title 41
Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia
###end article-title 41
###begin article-title 42
###xml 123 127 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1beta and IL-6 concentrations
###end article-title 42
###begin article-title 43
Cytokine production in obsessive-compulsive disorder
###end article-title 43
###begin article-title 44
###xml 20 24 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Plasma interleukin-1beta and tumor necrosis factor concentrations in obsessive-compulsive disorders
###end article-title 44
###begin article-title 45
###xml 14 19 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Decreased TNF-alpha and NK activity in obsessive-compulsive disorder
###end article-title 45
###begin article-title 46
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder
###end article-title 46
###begin article-title 47
Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls
###end article-title 47
###begin article-title 48
###xml 18 26 <span type="species:ncbi:9606">children</span>
Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever
###end article-title 48
###begin article-title 49
The pathophysiology of tumor necrosis factors
###end article-title 49
###begin article-title 50
Cytokines and the nervous system I: expression and recognition
###end article-title 50
###begin article-title 51
Cytokines and the nervous system II: actions and mechanisms of action
###end article-title 51
###begin article-title 52
###xml 93 98 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 41 56 <span type="species:ncbi:10090">transgenic mice</span>
Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha
###end article-title 52
###begin article-title 53
Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition
###end article-title 53
###begin article-title 54
Interleukin-6 and its receptor in autoimmunity
###end article-title 54
###begin article-title 55
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain
###end article-title 55
###begin article-title 56
Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain
###end article-title 56
###begin article-title 57
DSM IV Eksen I bozukluklari icin yapilandirilmis klinik gorusmenin Turkce'ye uyarlanmasi ve guvenilirlik calismasi
###end article-title 57
###begin article-title 58
The Yale-Brown obsessive compulsive scale. II. Validity
###end article-title 58
###begin article-title 59
A rating scale for depression
###end article-title 59
###begin article-title 60
The assessment of anxiety states by rating
###end article-title 60
###begin article-title 61
Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale
###end article-title 61
###begin article-title 62
Hamilton Anksiyete Degerlendirme Olcegi, degerlendiriciler arasi guvenirlik ve gecerlik calismasi
###end article-title 62
###begin article-title 63
Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease
###end article-title 63
###begin article-title 64
Serotonin-1D hypothesis of obsessive-compulsive disorder: an update
###end article-title 64
###begin article-title 65
Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6
###end article-title 65
###begin article-title 66
###xml 36 40 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 83 88 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations
###end article-title 66
###begin article-title 67
Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania
###end article-title 67
###begin article-title 68
Cytokines and the brain: implications for clinical psychiatry
###end article-title 68
###begin article-title 69
Cytokine production and treatment response in major depressive disorder
###end article-title 69
###begin article-title 70
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients
###end article-title 70
###begin article-title 71
Autoimmunity in schizophrenia: a review of recent findings
###end article-title 71
###begin article-title 72
Influence of age of onset on clinical features in obsessive-compulsive disorder
###end article-title 72
###begin article-title 73
Benzodiazepines, anxiety and immunity
###end article-title 73
###begin article-title 74
The immunoregulatory effects of antidepressants
###end article-title 74
###begin article-title 75
###xml 47 55 <span type="species:ncbi:9606">patients</span>
The influence of olanzapine on immune cells in patients with schizophrenia
###end article-title 75
###begin article-title 76
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
###end article-title 76
###begin article-title 77
T cell subsets in obsessive-compulsive disorder
###end article-title 77
###begin article-title 78
Olanzapine and obsessive-compulsive symptoms
###end article-title 78
###begin article-title 79
Evidence for an immune response in major depression: a review and hypothesis
###end article-title 79
###begin article-title 80
Brain-immune interactions in neuropsychiatry: highlights of the basic science and relevance to pathogenic factors and epiphenomena
###end article-title 80
###begin article-title 81
Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function?
###end article-title 81
###begin article-title 82
Immunology of obsessive-compulsive disorder
###end article-title 82
###begin title 83
Figures and Tables
###end title 83
###begin p 84
Demographic and clinical characteristics of the subjects.
###end p 84
###begin p 85
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
TNF-alpha and IL-6 levels in the patients with obsessivecompulsive disorder and control group.
###end p 85

